Clinical Trial Update: Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update for ALZT-OP1 in early Alzheimer's disease with completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• ALZT-OP1

Snippet

Sponsor: AZTherapies, Inc. | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED